Literature DB >> 7654445

Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989.

L A Kiemeney1, J W Coebergh, N P Koper, L H van der Heijden, R P Pauwels, R F Schapers, A L Verbeek.   

Abstract

Trends in cancer occurrence and survival may reflect changing risks and prognosis, respectively, but may also be caused by changes in detection, classification and registration. Changed classification of low-stage papillary carcinomas may have a material effect on observed trends in the occurrence of bladder cancer. We studied the effect of the implementation of the WHO grading system and the third edition of the TNM staging system on bladder cancer incidence in the south-eastern part of the Netherlands. Data on superficial and invasive bladder cancer incidence between 1975 and 1989 were derived from the population-based Eindhoven cancer registry. Data on survival of patients with stages I-IV bladder cancer were derived from the municipal population registers. Age-adjusted bladder cancer incidence per 100,000 person-years rose from 25.9 to 40.7 in males and from 3.1 to 8.5 in females. This increasing trend was caused almost entirely by non-invasive pTa papillary carcinoma. A considerable shift was observed towards lower disease stages, which was less evident within the group of invasive tumours. The relative 5-year survival of patients with stages I-IV invasive bladder cancer was 59% in 1975-1977 and 70% in 1984-1986. After stratification by stage, however, no striking improvement was observed in the prognosis. We conclude that the increasing trend of bladder cancer occurrence in the Netherlands since 1975 has largely been caused by changed classification systems and reporting procedures for pTa tumours (formerly classified as papillomas).

Entities:  

Mesh:

Year:  1994        PMID: 7654445     DOI: 10.1016/0959-8049(94)90472-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Sex disparities in cancer mortality and survival.

Authors:  Michael B Cook; Katherine A McGlynn; Susan S Devesa; Neal D Freedman; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

Review 2.  Explanations for worsening cancer survival.

Authors:  Esther de Vries; Henrike E Karim-Kos; Maryska L G Janssen-Heijnen; Isabelle Soerjomataram; Lambertus A Kiemeney; Jan Willem W Coebergh
Journal:  Nat Rev Clin Oncol       Date:  2010-01       Impact factor: 66.675

3.  Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder.

Authors:  Luis A Kluth; Harun Fajkovic; Evanguelos Xylinas; Joseph J Crivelli; Niccolo Passoni; Morgan Rouprêt; Andreas Becker; Evi Comploj; Armin Pycha; Sten Holmang; Amit Gupta; Yair Lotan; Pierre I Karakiewicz; Paolo Gontero; Felix K-H Chun; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  World J Urol       Date:  2012-11-30       Impact factor: 4.226

4.  The present and future burden of urinary bladder cancer in the world.

Authors:  Martine Ploeg; Katja K H Aben; Lambertus A Kiemeney
Journal:  World J Urol       Date:  2009-02-15       Impact factor: 4.226

5.  Incidence trends of urinary bladder and kidney cancers in urban Shanghai, 1973-2005.

Authors:  Yang Yang; Li Xie; Jia-Li Zheng; Yu-Ting Tan; Wei Zhang; Yong-Bing Xiang
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

6.  Clinicopathological Significance of Estrogen Receptor β and Estrogen Synthesizing/Metabolizing Enzymes in Urothelial Carcinoma of Urinary Bladder.

Authors:  Naomi Sato; Kazue Ise; Shuko Hata; Shinichi Yamashita; Akihiro Ito; Hironobu Sasano; Yasuhiro Nakamura
Journal:  Pathol Oncol Res       Date:  2021-04-15       Impact factor: 3.201

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.